714 related articles for article (PubMed ID: 17323311)
1. Multiple-arm superiority and non-inferiority designs with various endpoints.
Chang M
Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
[TBL] [Abstract][Full Text] [Related]
2. Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials.
Lai TL; Shih MC; Zhu G
Stat Med; 2006 Apr; 25(7):1149-67. PubMed ID: 16189814
[TBL] [Abstract][Full Text] [Related]
3. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo.
Pigeot I; Schäfer J; Röhmel J; Hauschke D
Stat Med; 2003 Mar; 22(6):883-99. PubMed ID: 12627407
[TBL] [Abstract][Full Text] [Related]
4. Adaptive design method based on sum of p-values.
Chang M
Stat Med; 2007 Jun; 26(14):2772-84. PubMed ID: 17133651
[TBL] [Abstract][Full Text] [Related]
5. Testing non-inferiority and superiority for two endpoints for several treatments with a control.
Lawrence J
Pharm Stat; 2011; 10(4):318-24. PubMed ID: 20949636
[TBL] [Abstract][Full Text] [Related]
6. Optimal design of clinical trials comparing several treatments with a control.
Marschner IC
Pharm Stat; 2007; 6(1):23-33. PubMed ID: 17323312
[TBL] [Abstract][Full Text] [Related]
7. A mixed approach for proving non-inferiority in clinical trials with binary endpoints.
Rousson V; Seifert B
Biom J; 2008 Apr; 50(2):190-204. PubMed ID: 18311852
[TBL] [Abstract][Full Text] [Related]
8. Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials.
Wang SJ; Hung HM; Tsong Y; Cui L
Stat Med; 2001 Jul; 20(13):1903-12. PubMed ID: 11427948
[TBL] [Abstract][Full Text] [Related]
9. Noninferiority testing beyond simple two-sample comparison.
Tsong Y; Chen WJ
J Biopharm Stat; 2007; 17(2):289-308. PubMed ID: 17365225
[TBL] [Abstract][Full Text] [Related]
10. Sample size determination in clinical trials with multiple co-primary binary endpoints.
Sozu T; Sugimoto T; Hamasaki T
Stat Med; 2010 Sep; 29(21):2169-79. PubMed ID: 20687162
[TBL] [Abstract][Full Text] [Related]
11. Sample size determination in superiority clinical trials with multiple co-primary correlated endpoints.
Sozu T; Sugimoto T; Hamasaki T
J Biopharm Stat; 2011 Jul; 21(4):650-68. PubMed ID: 21516562
[TBL] [Abstract][Full Text] [Related]
12. Blinded sample size reestimation in non-inferiority trials with binary endpoints.
Friede T; Mitchell C; Müller-Velten G
Biom J; 2007 Dec; 49(6):903-16. PubMed ID: 17726715
[TBL] [Abstract][Full Text] [Related]
13. Re-formulating non-inferiority trials as superiority trials: The case of binary outcomes.
Durkalski VL; Berger VW
Biom J; 2009 Feb; 51(1):185-92. PubMed ID: 19197960
[TBL] [Abstract][Full Text] [Related]
14. The assessment of non-inferiority in a gold standard design with censored, exponentially distributed endpoints.
Mielke M; Munk A; Schacht A
Stat Med; 2008 Nov; 27(25):5093-110. PubMed ID: 18570271
[TBL] [Abstract][Full Text] [Related]
15. Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat.
Matilde Sanchez M; Chen X
Stat Med; 2006 Apr; 25(7):1169-81. PubMed ID: 16397861
[TBL] [Abstract][Full Text] [Related]
16. An examination of the efficiency of the sequential parallel design in psychiatric clinical trials.
Tamura RN; Huang X
Clin Trials; 2007; 4(4):309-17. PubMed ID: 17848492
[TBL] [Abstract][Full Text] [Related]
17. A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials.
Schwartz TA; Denne JS
Stat Med; 2006 Oct; 25(19):3396-406. PubMed ID: 16900573
[TBL] [Abstract][Full Text] [Related]
18. Exact sample-size determination in testing non-inferiority under a simple crossover trial.
Lui KJ; Chang KC
Pharm Stat; 2012; 11(2):129-34. PubMed ID: 22232060
[TBL] [Abstract][Full Text] [Related]
19. Analysis of time-to-event data under a two-stage survival adaptive design in clinical trials.
Lu Q; Tse SK; Chow SC
J Biopharm Stat; 2010 Jul; 20(4):705-19. PubMed ID: 20496201
[TBL] [Abstract][Full Text] [Related]
20. Two-stage designs for dose-finding trials with a biologic endpoint using stepwise tests.
Polley MY; Cheung YK
Biometrics; 2008 Mar; 64(1):232-41. PubMed ID: 17573866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
